Source: International Congress 2015 – Regenerative medicine of the lung: opportunities and threats



Rating:

Share or cite this content

Citations should be made in the following way:
Hans-Willem Snoeck (New York, United States of America). Modelling human lung development and disease using pluripotent stem cells. International Congress 2015 – Regenerative medicine of the lung: opportunities and threats

Member's Comments

No comment yet.

Related content which might interest you: 3D models of human lung development and disease using pluripotent stem cells Source: International Congress 2019 – From 2D to 3D models of human lung disease: novel developments to rebuild the lung Year: 2019 Induced pluripotent stem cells for generating lung airway stem cells and modelling respiratory disease Source: Eur Respir Monogr 2021; 91: 190-204 Year: 2021 Induced pluripotent stem cells for generating lung alveolar epithelial cells and modelling respiratory disease Source: Eur Respir Monogr 2021; 91: 205-221 Year: 2021 iPSC derived lung stem cells as tools to understand lung regeneration and disease Source: ERS Lung Science Conference 2021 Year: 2021 Using induced pluripotent stem cells to model the human lung alveolar epithelium Source: International Congress 2018 – Pathophysiology of the human lung alveolus Year: 2018 Progress towards human lung regeneration in end-stage respiratory failure: studying human lung development in vitro using organoid cultures of human embryonic lung stem cells Source: International Congress 2018 – Cell-matrix interactions in lung disease and regeneration Year: 2018 Pulmonary transplantation of human induced pluripotent stem cell-derived macrophages Source: International Congress 2019 – Airway regenerative medicine: from bench to bedside Year: 2019 The therapeutic potential of the mesenchymal stem cell secretome in a mouse model of chronic inflammatory lung disease Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Lung stem cells and the role of the stem cell niche Source: International Congress 2019 – From 2D to 3D models of human lung disease: novel developments to rebuild the lung Year: 2019 Metabolic reprogramming by mesenchymal stem cells as a strategy for lung repair Source: ERS Lung Science Conference 2020 Year: 2020 Derivation of epithelial-only airway organoids from human pluripotent stem cells Source: International Congress 2019 – Airway regenerative medicine: from bench to bedside Year: 2019 How can gene-editing of human pluripotent stem cells help cystic fibrosis? Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis Year: 2019 Characterization of human mesenchymal stem cells phenotype and secretome in a in vitro model of acute lung injury inflammation Source: Annual Congress 2011 - Lung cell injury and repair Year: 2011 Stepwise derivation of distal lung epithelial progenitors from murine embryonic stem cells Source: Eur Respir J 2005; 26: Suppl. 49, 175s Year: 2005 Diversity in mesenchymal lineages during early human lung development Source: International Congress 2018 – Molecular and cellular determinants of the developing lung Year: 2018 Oral presentation: Mesenchymal induction of lung endoderm progenitor cells from embryonic stem cells Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis Year: 2009 Mesenchymal cells, immune cells and the lung stem cell niche Source: Eur Respir Monogr 2021; 91: 134-143 Year: 2021 IPF lung resident mesenchymal stem cells differentiate into epithelial cells displaying a disease-specific transcriptome Source: International Congress 2019 – Intercellular communication in tissue remodelling of chronic lung diseases Year: 2019 Rescue of murine silica-induced lung injury and fibrosis by human embryonic stem cells Source: Eur Respir J 2012; 39: 446-457 Year: 2012